Republic Republic Republic
  • Log in
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
Primary market Live deals Secondary market Buy and sell Republic Note Own a piece of Republic's upside Investor Network Membership Receive exclusive discounts and benefits
Republic Venture Opportunities for accredited investors
Republic Capital Multi-stage venture firm Republic Digital Crypto hedge fund
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain Asset management Explore digital asset funds
Republic Capital In-house Venture Capital fund Broker dealer Regulated capital services
Log in Sign up

Republic Republic Republic
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
  • US
  • Log in
  • Sign up
All investors
Primary market Live deals Secondary market Buy and sell Republic Note Own a piece of Republic's upside Investor Network Membership Receive exclusive discounts and benefits
Accredited only
Republic Venture Opportunities for accredited investors
Institutional
Republic Capital Multi-stage venture firm Republic Digital Crypto hedge fund
More
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Spotlight deal
Hamilton Lane Private Infrastructure Fund
Hamilton Lane Private Infrastructure Fund
Get unique access to the full spectrum of private markets with Hamilton Lane
Growth capital solutions
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets
Sharedrops Gift equity as a reward
Web3 services
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain Asset management Explore digital asset funds
Institutional services
Republic Capital In-house Venture Capital fund
Broker dealer Regulated capital services

Evolution Devices isn't accepting new investments

Evolution Devices’ deadline was September 6, 2023

Follow the company to stay updated on their progress, including future investment opportunities


Explore new investment opportunities:
View companies raising now
Campaign ended
Logo of Evolution Devices

Evolution Devices

Enhancing human movement with digital therapy and 3D biomechanics
B2B Subscription Latinx Founders Wellbeing & Longevity Healthtech Deep Tech AI & Machine Learning Wearables
Facebook Telegram Twitter LinkedIn
Featured image of Evolution Devices
$149,548
Raised
154
Investors
Successfully funded and closed on September 6, 2023.
Invest in Evolution Devices

Open for investment

Investors in Evolution Devices also invested in these companies. View more
Logo of Eli Roth's The Horror Section

Eli Roth's The...

A brand-new independent studio from an iconic horror...

Republic Funding Portal · Reg CF
Logo of RYSE

RYSE

Smart Shades for your Smart Home - over $9mm in sale...

Capital R · Reg A+
Loading...
Pitch Updates 1 Reviews 14
Invest Invest in Evolution Devices
Facebook Telegram Twitter LinkedIn
Closed on September 6, 2023. Information may not be up-to-date. Campaign closed on September 6, 2023. Information displayed may not be up-to-date.
Problem Solution phase 2 Solution phase 1 Traction Biz. model Market Competition Vision and strategy Impact Funding Founders Summary
About Team

Documents

Republic (OpenDeal Portal LLC, CRD #283874) is hosting this Reg CF securities offering by Evolution Devices, Inc.. View the official SEC filing and all updates:
Official SEC Logo Form C SEC.gov
Company documents
Evolution Devices Crowd SAFE Evolution Devices Form C.pdf
Loading

Hear from some of the 154 investors in Evolution Devices


Show more

Highlights


  • EVOWALK: Patented digital therapy solution for foot drop & mobility issues
  • EVOVISION: Next-gen biomechanics & motion capture for full-body movement
  • 1000+ waitlisted patients | 10 rehab clinics onboarded
  • 2023: Studies complete (Q1) | FDA app submitted (Q1) | 500 devices (Q4)
  • Partners: UCSF, MRRI, Mass General Brigham, Shirley Ryan Ability Lab
  • Backed by Toyota Mobility, National Inst. of Health, National Science Fndn.

Problem


Our mission is to enhance human movement

We are enhancing the way people learn any new physical skill — from walking, running, and exercise, to fine motor skills such as playing the piano.

Our initial area of focus is enhancing mobility.


  • Outdated canes, walkers, and braces are the standard of care and can lead to deteriorating walking health.
  • There is a massive opportunity to enhance mobility and track movement data with A.I. based tools and therapy


Solution phase 1


EVOWALK:
Smart device-powered
mobility therapy

Evolution Devices is revolutionizing mobility health through our connected digital health platform — starting with walking rehab. We're restoring and prolonging mobility for people with mobility impairments.

The EVOWALK platform is a digital therapy solution built around an AI-powered muscle stimulation device. The EVOWALK device gathers detailed walking data and provides electrotherapy to stimulate muscles at the right time to rehab walking and prevent falls. Patients and their physical therapists use data generated by the proprietary EVOWALK AI to set personalized goals and care plans.

Stroke survivor able to lift paralyzed foot with EVOWALK smart stimulation

Your browser does not support HTML5 video.

EVOWALK On/Off effect demonstrated by a person living with a 
mobility impairment due to Multiple Sclerosis

Your browser does not support HTML5 video.

—

In preliminary studies of 8 weeks, we see up to a 10x increase in steps per day and a 20% increase in walking speed with the EVOWALK.

EVOWALK is used on average 6 hrs/day. This voluntary high adherence leads to novel, real-world walking data collected and used to improve and personalize care plans. 

Traction


Planned growth for 2023


Recent & upcoming milestones

  • Formative studies completed Q4 2021
  • Patented System Q1 2022
  • Abstract published with a poster presentation at the Consortium of Multiple Sclerosis Centers Q2 2022
  • Paid research pilots Q4 2022 
  • Usability studies completed Q4 2022
  • IEC/EMC Testing Completed Q1 2023
  • FDA 510(k) submission Q1 2023
  • First articles manufactured Q2 2023
  • FDA Clearance projected Q4 2023
  • Sell initial 50 EVOWALKs Q4 2023
  • Manufacture 500 EVOWALKs Q4 2023 - Q1 2024
  • 10 rehab clinics onboarded (~20 patients per clinic)
  • 1000+ patients waitlisted for launch


Business model


Subscription-based B2B2C

$3k/clinical package
—
$85+/month SaaS + consumables

  • Clinics purchase EVOWALK Clinical package
    • Remote care package included
    • Clinician Certification program
    • Enables remote monitoring as of 2022 (clinics need this now)
  • Patients purchase EVOWALK device after completing course of care

Achievable high growth with 9x LTV/CAC



Market


$6B initial and
$45B growing market

EVOWALK is initially focused on solving mobility issues for the estimated 5M people living with a neurological walking impairment. There is a clear regulatory pathway for FDA clearance and a strong need for new technology in this initial market. We estimate a $6B market with our B2B2C model with a 35% market share target (1.8M people). 

EVOWALK is built to assist other walking impairments. With further research and development, we plan on improving mobility for the aging population and providing pain relief for those with osteoarthritis. These solutions will likely have different pricing structures, but open up EVOWALK to large market opportunities with minimal software and hardware development.

Focusing on lower-limb mobility alone, there is a $45B total market opportunity. There is significant room for Evolution Devices to take a large portion of the market with our AI-based solutions.

Competition


IoT and AI solution for enhanced mobility

EVOWALK has innovated over its competition through our use of modern technological advancements in IoT and AI to create a sleek, effective, and affordable solution to expand the market opportunity. EVOWALK patented AI system (March 2022) aims to be the first FDA-Cleared AI-based solution for foot drop. AI reduces the need for constant adjustment of stimulation timing and can adapt to different walking styles, positioning the EVOWALK to be extremely effective to treat and track mobility impairments and collect real-world walking data to personalize care for everyone.

Vision and strategy


Freedom of mobility is a human right

Evolution Devices’ mission is to create accessible and innovative technology to assist and enhance human movement. 

We believe freedom of mobility is a fundamental human right. Our vision is to lead the evolution of human movement with cutting-edge technologies enabling anyone, anywhere, to receive personalized rehab care and movement training. Starting with walking impairments from neurotrauma, our vision is to expand our ecosystem to rehab and enhance all types of physiological movements. 

With your investment, you can help us achieve our vision to shape the future of human movement.

—
Phase II: EVOVISION
3D Markerless motion capture for biomechanics
—

EVOVISION is a 3D Markerless motion capture system built to collect accurate, high-quality biomechanics quicker and easier than ever. 


EVOVISION is initially focused on providing a solution for gait labs in rehab centers and children's hospitals. The data from EVOVISION will inform care plans and is currently being beta tested at different hospitals across the US, including Shirley Ryan Ability Lab. The EVOVISION is supported by a National Science Foundation Phase II grant — a highly competitive grant awarded by the NSF.

EVOVISION adds to the expansive proprietary biomechanics data the Evolution Devices platform collects. As our platform collects more movement data, we are continuing to work to expand our ecosystem of devices and personalized training to not only assist people living with impairment but also train people in quickly learning any new movement.


Your browser does not support HTML5 video.


Impact


Why now?

Funding


Backed by leading institutions

We’ve raised over $2.5M in funding to date. Notable investors include the Alchemist Accelerator Program and Edge Systems founder Bill Cohen, who led the medical device company to a $150M exit. A large portion of our funding comes from non-dilutive grants from prestigious institutions, including:

  • National Science Foundation (Phase I and II Recipients)
  • Toyota Mobility Foundation

  • Bristol Myers Squibb

  • National Institute of Health

—
With this investment, we have the opportunity for
NSF Phase IIB non-dilutive funding for up to $500k
for EVOVISION expansion.
—

Founders


An award-winning team with personal motivation

Our team of neuroscientists, medical device engineers, and neuro-specialist physical therapists have backgrounds from UC Berkeley, Vanderbilt, and UCSF. Our advisors and mentors have successfully commercialized and grown medical device businesses in the past.

Our founders are personally connected to the problem — they were inspired to build Evolution Devices to help Pierluigi’s father, who struggles with Multiple Sclerosis and has since slowly been losing his ability to walk. 

Pierluigi Mantovani (Co-founder & CEO) is responsible for Evolution Devices’ strategy, partnerships, and fundraising. Mantovani is a healthcare entrepreneur and former Neuroscience researcher at UCSF, where he worked in the lab of neurosurgeon Dr. Edward Chang, developing technology and tools to stimulate the brain directly for combatting different neurological impairments. He received his BA in Cognitive Science from UC Berkeley and was inspired to build Evolution Devices to help his father, who lives with Multiple Sclerosis. 

Juan M. Rodriguez (Co-founder & CTO) leads the technical development at Evolution Devices. Rodriguez is an electrical engineer and computer scientist. He received his BS in Electrical Engineering and Computer Science from UC Berkeley. Juan performed research at Princeton University, where he helped with the development of a large-scale strain sensing system that could be used for health monitoring and to integrate into IoT and smart buildings. Rodriguez has a personal interest in creating technologies that restore and enhance human capability after his grandfather lost mobility on the right side of his body due to a brain tumor.



Lili Karashchuk PhD (Co-founder & Chief Science Officer) leads the machine learning and computer vision development at Evolution Devices. Karashchuk received their BA in Statistics and Computer Science from UC Berkeley and is completing their Ph.D. in Neuroscience at the University of Washington. 

Deal terms


Valuation cap
$18M
The maximum valuation at which your investment converts into equity shares or cash.
Learn more.
Minimum investment
$250
The smallest investment amount that Evolution Devices is accepting.
Learn more
Maximum investment
$124K
The largest investment amount that Evolution Devices is accepting.
Learn more
Funding goal
$25K / $618K
100% of $25K minimum offering amount has been reached.

Evolution Devices needs to raise $25K before the deadline. The maximum amount Evolution Devices is willing to raise is $618K.
Learn more
Deadline
September 6, 2023
Evolution Devices needs to reach their minimum funding goal before the deadline (). If they don’t, all investments will be refunded.
Learn more
Security type
Crowd SAFE
A SAFE allows an investor to make a cash investment in a company, with rights to receive certain company stock at a later date, in connection with a specific event.
Learn more
Nominee Lead
Chief Executive Officer of Evolution Devices (currently Pierluigi Mantovani
Logo of Evolution Devices
Evolution Devices
Enhancing human movement with digital therapy and 3D biomechanics
Raised amount Valuation cap
0 — $100,000 $15M
$100,000.01 — $618,000 $18M
Close
How it works

Documents

Republic (OpenDeal Portal LLC, CRD #283874) is hosting this Reg CF securities offering by Evolution Devices, Inc.. View the official SEC filing and all updates:
Official SEC Logo Form C SEC.gov
Company documents
Evolution Devices Crowd SAFE Evolution Devices Form C.pdf

About Evolution Devices

Legal Name
Evolution Devices, Inc.
Founded
Jul 2017
Form
Delaware Corporation
Employees
7
Website
evolutiondevices.com
Social Media
Headquarters
Google Map location of of Evolution Devices
1111 Broadway Floor 3 , Oakland, CA
Headquarters
1111 Broadway, Floor 3, Oakland, CA, United States 94607

Evolution Devices Team
Everyone helping build Evolution Devices, not limited to employees

Profile picture of Pierluigi Mantovani
Pierluigi Mantovani
Founder
Featured in Superheroes · Read
Profile picture of Juan Rodriguez
Juan Rodriguez
CTO
Pierluigi Mantovani
Founder
Juan Rodriguez
CTO
Logo of Evolution Devices

Evolution Devices

Evolution Devices successfully raised $149,548 from 154 investors on September 6, 2023
Republic

Giving everyone access to early-stage startup investing

For investors
  • Why invest
  • How it works
  • FAQ
  • Risks
  • Privacy policy
  • Accessibility
  • Cookie Preferences
  • Form CRS
For startups
  • Why raise
  • Learn
  • FAQ
  • Instruments
  • Crowd SAFE
  • Tokenized assets
Company
  • About
  • Journal
  • Events
  • Contact
  • We're hiring!
Dollar Refer a startup, get $2,500
Dollar Refer a startup, get $2,500

Invest in the app

Android app iOS app

Invest in the app

Android app iOS app

This site (the "Site") is owned and maintained by OpenDeal Inc., which is not a registered broker-dealer. OpenDeal Inc. does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this Site is the responsibility of, the applicable issuer of such securities. The intermediary facilitating the offering will be identified in such offering’s documentation.

All related securities activity is conducted by OpenDeal Broker LLC a registered broker-dealer, Member of FINRA and SiPC, an affiliate of OpenDeal Inc. and OpenDeal Portal LLC, located at 149 5th Avenue, 10th Floor, New York, NY 10010. Please check our background on FINRA’s BrokerCheck.

Certain pages discussing the mechanics and providing educational materials regarding regulation crowdfunding offerings may refer to OpenDeal Broker LLC and OpenDeal Portal LLC collectively as “Republic”, solely for explanatory purposes.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC make investment recommendations and no communication, through this Site, or in any other medium, should be construed as a recommendation for any security offered on or off this investment platform. Investment opportunities posted on this Site are private placements of securities that are not publicly traded, involve a high degree of risk, may lose value including the total loss of invested capital, are subject to holding period requirements and are intended for investors who do not need a liquid investment. Past performance is not indicative of future results. Investors must be able to afford the loss of their entire investment. Only qualified investors, who understand the risks of early-stage investment and who meet the Republic's investment criteria may invest. Investors may be restricted to only Accredited Investors or non-U.S. persons, to invest in offerings hosted by OpenDeal Broker. Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC, nor any of their officers, directors, agents and employees make any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy or completeness of any information on this Site or the use of information on this site. Offers to sell securities can only be made through official offering documents that contain important information about the investment and the issuers, including risks. Investors should carefully read the offering documents. Investors should conduct their own due diligence and are encouraged to consult with their tax, legal and financial advisors.

By accessing the Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy. Please also see OpenDeal Broker’s Business Continuity Plan and Additional Risk Disclosures. All issuers offering securities under regulation crowdfunding as hosted by OpenDeal Portal LLC are listed on the All Companies Page. The inclusion or exclusion of an issuer on the Platform Page and/or Republic’s Homepage, which includes offerings conducted under regulation crowdfunding as well as other exemptions from registration, is not based upon any endorsement or recommendation by OpenDeal Inc, OpenDeal Portal LLC, or OpenDeal Broker LLC, nor any of their affiliates, officers, directors, agents, and employees. Rather, issuers of securities may, in their sole discretion, opt-out of being listed on the Platform Page and Homepage.

Investors should verify any issuer information they consider important before making an investment.

Investments in private companies are particularly risky and may result in total loss of invested capital. Past performance of a security or a company does not guarantee future results or returns. Only investors who understand the risks of early stage investment and who meet the Republic's investment criteria may invest.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC verify information provided by companies on this Site and makes no assurance as to the completeness or accuracy of any such information. Additional information about companies fundraising on the Site can be found by searching the EDGAR database, or the offering documentation located on the Site when the offering does not require an EDGAR filing.

To help the government fight the funding of terrorism and money laundering activities, Federal law requires all financial institutions to obtain, verify, and record information that identifies each person who opens an account. Therefore, when you use the Services we will ask for your name, address, date of birth, and other information that will allow us to identify you. We may also ask to see your driver's license, passport or other identifying documents.

Republic and its affiliates are not and do not operate or act as a bank. Certain banking services are provided by BankProv, member FDIC / member DIF. FDIC coverage only applies in the event of bank failure. Digital (crypto) assets and investment products are not insured by the FDIC, may lose value, and are not deposits or other obligations of BankProv and are not guaranteed by BankProv. Terms and conditions apply.

Invest in startups using your credit card
You can invest using your credit card

Made in SF/NYC